Akums Drugs and Pharmaceuticals Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting

Akums' board approved consolidated FY26 results: Profit ₹256.40 Cr, EPS ₹16.67. They proposed a total dividend of ₹3.00/share. Additionally, ₹4.81 Cr from excess IPO expense provision was reallocated for acquisitions & general corporate purposes.